Clarus Therapeutics Holdings OverviewClarus Therapeutics Holdings Net Income
Profitability analysis for CRXT.
Quarterly Net Income
-$12.71M
↑ 29.82% YoY
As of Jun 2022
Annual Net Income (TTM)
-$58.62M
↓ 2742.62% YoY
Trailing 12 months ending Jun 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...